Exposure-Efficacy Meta-model of Nintedanib in Adult Patients with Chronic Fibrosing Interstitial Lung Diseases

MIDD

Regulatory interactions

Specific populations

Pharmacometrics

Respiratory

Program strategies and efficiencies

Methodology

Hartman S, Janssen J, Ribbing J, Stowasser S, Korell J